Michelle E. Maglio

2.4k total citations
9 papers, 359 citations indexed

About

Michelle E. Maglio is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Michelle E. Maglio has authored 9 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 8 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Michelle E. Maglio's work include Multiple Myeloma Research and Treatments (8 papers), Peptidase Inhibition and Analysis (6 papers) and Protein Degradation and Inhibitors (5 papers). Michelle E. Maglio is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), Peptidase Inhibition and Analysis (6 papers) and Protein Degradation and Inhibitors (5 papers). Michelle E. Maglio collaborates with scholars based in United States, France and United Kingdom. Michelle E. Maglio's co-authors include Paul G. Richardson, Jacob P. Laubach, Cindy Varga, Irene M. Ghobrial, Kenneth C. Anderson, Constantine S. Mitsiades, Robert F. Cornell, Javid J. Moslehi, Weijuan Li and David Gailani and has published in prestigious journals such as British Journal of Haematology, Pharmacological Research and JAMA Oncology.

In The Last Decade

Michelle E. Maglio

9 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michelle E. Maglio United States	8	215	188	149	39	33	9	359
Rajesh Belani United States	12	131 0.6×	190 1.0×	178 1.2×	32 0.8×	37 1.1×	26	434
Christy Samaras United States	13	264 1.2×	302 1.6×	189 1.3×	28 0.7×	97 2.9×	57	437
Adam Bryant Australia	12	180 0.8×	202 1.1×	69 0.5×	13 0.3×	24 0.7×	29	497
Angelo Belotti Italy	14	312 1.5×	245 1.3×	201 1.3×	23 0.6×	82 2.5×	41	451
Thomas G Martin United States	10	369 1.7×	318 1.7×	263 1.8×	60 1.5×	36 1.1×	19	504
Samah Nassereddine United States	9	199 0.9×	118 0.6×	78 0.5×	12 0.3×	66 2.0×	20	375
M. Fox United States	4	487 2.3×	380 2.0×	297 2.0×	17 0.4×	63 1.9×	9	563
Cécile Bally France	10	335 1.6×	208 1.1×	70 0.5×	17 0.4×	101 3.1×	27	435
Ashwin Sridharan United States	7	78 0.4×	132 0.7×	96 0.6×	14 0.4×	46 1.4×	17	308
Amr Hanbali United States	9	104 0.5×	108 0.6×	74 0.5×	11 0.3×	28 0.8×	43	301

Countries citing papers authored by Michelle E. Maglio

Since Specialization

Citations

This map shows the geographic impact of Michelle E. Maglio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle E. Maglio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle E. Maglio more than expected).

Fields of papers citing papers by Michelle E. Maglio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle E. Maglio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle E. Maglio. The network helps show where Michelle E. Maglio may publish in the future.

Co-authorship network of co-authors of Michelle E. Maglio

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle E. Maglio. A scholar is included among the top collaborators of Michelle E. Maglio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle E. Maglio. Michelle E. Maglio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Varga, Cindy, Michelle E. Maglio, Irene M. Ghobrial, & Paul G. Richardson. (2018). Current use of monoclonal antibodies in the treatment of multiple myeloma. British Journal of Haematology. 181(4). 447–459. 33 indexed citations

Richardson, Paul G., Brandon M. Triplett, Vincent T. Ho, et al.. (2018). Defibrotide sodium for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome. Expert Review of Clinical Pharmacology. 11(2). 113–124. 21 indexed citations

Fradley, Michael G., John D. Groarke, Jacob P. Laubach, et al.. (2017). Recurrent cardiotoxicity potentiated by the interaction of proteasome inhibitor and immunomodulatory therapy for the treatment of multiple myeloma. British Journal of Haematology. 180(2). 271–275. 17 indexed citations

Richardson, Paul G., Philippe Moreau, Jacob P. Laubach, et al.. (2016). Deacetylase inhibitors as a novel modality in the treatment of multiple myeloma. Pharmacological Research. 117. 185–191. 26 indexed citations

Li, Weijuan, David García, Robert F. Cornell, et al.. (2016). Cardiovascular and Thrombotic Complications of Novel Multiple Myeloma Therapies. JAMA Oncology. 3(7). 980–980. 69 indexed citations

Varga, Cindy, Wanling Xie, Jacob P. Laubach, et al.. (2015). Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide–bortezomib combinations. British Journal of Haematology. 169(6). 843–850. 60 indexed citations

Guidetti, Anna, Jacob P. Laubach, Cindy Varga, et al.. (2014). Pomalidomide for the treatment of relapsed and refractory multiple myeloma. Expert Opinion on Orphan Drugs. 2(10). 1089–1108. 1 indexed citations

Chauhan, Dharminder, Jacob P. Laubach, Claire Fabre, et al.. (2012). New Proteasome Inhibitors in Myeloma. Current Hematologic Malignancy Reports. 7(4). 258–266. 73 indexed citations

Richardson, Paul G., Selim Corbacioglu, Vincent T. Ho, et al.. (2012). Drug safety evaluation of defibrotide. Expert Opinion on Drug Safety. 12(1). 123–136. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact